Liquidia Corporation

09/16/2024 | Press release | Distributed by Public on 09/16/2024 07:45

Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.